Cargando…
NIR-PIT: Will it become a standard cancer treatment?
Autores principales: | Furusawa, Aki, Choyke, Peter L., Kobayashi, Hisataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523356/ https://www.ncbi.nlm.nih.gov/pubmed/36185287 http://dx.doi.org/10.3389/fonc.2022.1008162 |
Ejemplares similares
-
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
por: Fukushima, Hiroshi, et al.
Publicado: (2022) -
Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts
por: Furumoto, Hideyuki, et al.
Publicado: (2022) -
CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model
por: Furusawa, Aki, et al.
Publicado: (2022) -
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin
por: Inagaki, Fuyuki F., et al.
Publicado: (2022) -
Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors
por: Maruoka, Yasuhiro, et al.
Publicado: (2020)